Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors
About this episode
This episode discusses the management of Alagille syndrome and the use of IBAT inhibitors in therapy.
Which patients with Alagille syndrome benefit from IBAT inhibitors, and what should you watch for during therapy? Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-management-alagille-syndrome-using-ileal-bile-2026a1000g3c?ecd=bdc_podcast_libsyn_mscpedu
Topics covered
- Alagille syndrome
- IBAT inhibitors
- patient management
- therapy monitoring
- medical education
Keywords
- Alagille syndrome
- IBAT inhibitors
- patient therapy
- medical management
- bile acid transport
Mentioned in this episode
Organizations: Medscape
Products: IBAT inhibitors
Places: Alagille syndrome
More episodes of Keeping Current
- Pharmacological and Combination Interventions for Nicotine Cessation
- Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
- The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
- Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
- Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes
Explore listener stats, chart rankings, contacts and more on the Keeping Current podcast page.